Altay Therapeutics Inc. is a biotechnology company dedicated to discovering innovative treatments for chronic inflammatory liver diseases and cancers. Founded in 2019 and based in San Bruno, California, the company specializes in developing small molecule therapies targeting transcriptional regulators known to drive various chronic conditions. Its research primarily focuses on curative therapies for diseases such as fibrosis, non-alcoholic steatohepatitis (NASH), rheumatoid arthritis, ulcerative colitis, and liver cancer. Altay's approach involves creating small molecules that inhibit the DNA interaction domain of transcriptional regulators, effectively turning off their target genes and addressing the underlying mechanisms of these diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.